Abelian Therapeutics

Acquired by Neumora
Explores Glia's role in brain disease, acquired by Neumora.

F-Prime Team

Sector

Life Sciences

Category

Therapeutics

Location

Boston, MA

Initial Investment

2017
Explores Glia's role in brain disease, acquired by Neumora.

Nascent biotech company harnessing emerging science on the importance of Glia in brain disease. Abelian Therapeutics was acquired in September 2020.